302: Vertex's big deal, biotech's red numbers, & an industry history lesson

How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss a multibillion-dollar deal from Vertex Pharmaceuticals with sweeping implications and a lengthy backstory. We also explain why gas prices are weighing on biotech, and make a surprise announcement.

Episode metadata supplied by the publisher feed · Published Apr 11, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

302: Vertex's big deal, biotech's red numbers, & an industry history lesson

0:00 24:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 24 minutes long.

When was this The Readout Loud episode published?

This episode was published on April 11, 2024.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!